» Articles » PMID: 36822320

Will Oral Food Challenges Still Be Part of Allergy Care in 10 Years' Time?

Overview
Date 2023 Feb 23
PMID 36822320
Authors
Affiliations
Soon will be listed here.
Abstract

Oral food challenges (OFCs) are currently the definitive diagnostic procedure in food allergy. Their design has evolved over the decades to maximize safety, optimize convenience, and address several specific clinical questions. However, they are a resource-intensive investigation that carry a risk for severe allergic reaction in which fatal outcomes, although rare, have been reported. In this review, we explore the many roles that OFC fulfil in the clinical and research settings. We also discuss progress that has been made in developing alternative diagnostic tools and how far these have reached in offering a viable replacement to OFC in clinical practice. Finally, we discuss the ongoing importance of research OFC to improve the future diagnostic capabilities of novel diagnostic tools.

Citing Articles

Genome-Wide Association Study Reveals a Causal Relationship Between Allergic Rhinitis and Hazelnut Allergy.

Sun Y, Vonk J, Kersten E, Qi C, Sprikkelman A, Koppelman G Allergy. 2024; 80(1):309-318.

PMID: 39673378 PMC: 11724235. DOI: 10.1111/all.16411.


The future of food allergy diagnosis.

Wong D, Santos A Front Allergy. 2024; 5:1456585.

PMID: 39575109 PMC: 11578968. DOI: 10.3389/falgy.2024.1456585.


Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study.

Vickery B, Bird J, Chinthrajah R, Jones S, Keet C, Kim E J Allergy Clin Immunol Pract. 2024; 12(11):2947-2954.

PMID: 39293782 PMC: 11560495. DOI: 10.1016/j.jaip.2024.08.056.


Understanding the heterogeneity of childhood allergic sensitization and its relationship with asthma.

Custovic A, Custovic D, Fontanella S Curr Opin Allergy Clin Immunol. 2024; 24(2):79-87.

PMID: 38359101 PMC: 10906203. DOI: 10.1097/ACI.0000000000000967.

References
1.
Alvarez Garcia O, Bartra J, Ruiz-Garcia M, Skypala I, Durham S, Boyle R . No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge. Allergy. 2021; 77(2):667-670. DOI: 10.1111/all.15130. View

2.
Yanagida N, Okada Y, Sato S, Ebisawa M . New approach for food allergy management using low-dose oral food challenges and low-dose oral immunotherapies. Allergol Int. 2016; 65(2):135-140. DOI: 10.1016/j.alit.2015.10.010. View

3.
Remington B, Krone T, Kim E, Bird J, Green T, Lack G . Estimated risk reduction to packaged food reactions by epicutaneous immunotherapy (EPIT) for peanut allergy. Ann Allergy Asthma Immunol. 2019; 123(5):488-493.e2. DOI: 10.1016/j.anai.2019.08.007. View

4.
Niggemann B, Lange L, Finger A, Ziegert M, Muller V, Beyer K . Accurate oral food challenge requires a cumulative dose on a subsequent day. J Allergy Clin Immunol. 2012; 130(1):261-3. DOI: 10.1016/j.jaci.2012.03.021. View

5.
Turner P, Gowland M, Sharma V, Ierodiakonou D, Harper N, Garcez T . Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2014; 135(4):956-963.e1. PMC: 4382330. DOI: 10.1016/j.jaci.2014.10.021. View